Anvisa (National Health Surveillance Agency) banned this Wednesday (23) the manufacture and sale of omegafix braiding ointment.
The measure, which also determines the withdrawal of the product from the shelves, was taken after cases of people who had eye problems with the use of the product circulated on the internet. The regulatory agency says it has opened a dossier to investigate the allegations.
According to Anvisa, the ointment is not regulated as a cosmetic in the body and, therefore, it is not possible to guarantee the safety of use.
The product is manufactured by Cape Indústria de Cosméticos and is available for purchase on several marketplaces.
Joana Cunha with Andressa Motter and Ana Paula Branco
your subscription can be worth even more
Do you already know the advantages of being a Folha subscriber? In addition to having access to reports and columns, you have exclusive newsletters (find out here). You can also download our free app from the Apple Store or Google Play to receive alerts on the top news of the day. Your subscription helps us to make independent and quality journalism. Thank you!
your subscription is worth a lot
More than 180 reports and analyzes published each day. A team with more than 120 columnists. A professional journalism that supervises the public power, conveys useful and inspiring news, counterpoints the intolerance of social networks and draws a clear line between truth and lie. How much does it cost to help produce this content?
sign the sheet
I have over 8 years of experience in the news industry. I have worked for various news websites and have also written for a few news agencies. I mostly cover healthcare news, but I am also interested in other topics such as politics, business, and entertainment. In my free time, I enjoy writing fiction and spending time with my family and friends.
